Search Results

Genestack Ltd. announced that its flagship multi-omics data catalog, curation and integrative search product, Omics Data Manager, has been licensed and implemented by a world-leading genomics research centre, the Wellcome Sanger Institute.

The Sanger Sequencing Services Market is expected to grow at a CAGR of 6.5% during the forecast period , according to latest analysis by Emergen Research.

Atrium Health’s Sanger Heart & Vascular Institute has received a Center of Excellence designation from Kerecis®, the company pioneering the use of fish skin and fatty acids in cellular therapy, tissue regeneration and protection.

The global sanger sequencing services market was valued at USD 1.6 billion in 2019 and is expected to reach USD 3.4 billion by 2027, growing at a CAGR of 10.1% from 2020 to 2027, according to latest study by Emergen Research.

Arima Genomics, Inc., a biotechnology company accelerating the adoption of the genome structure information, announced today that its new high-coverage HiC technology has been evaluated and implemented at the Wellcome Sanger Institute for projects, including the Darwin Tree of Life project, in an effort to explore the true genetic diversity between species and between individuals within a species. The Wellcome Sanger Insti

Sanger sequencing is one of the oldest DNA sequencing methods carried out using oligonucleotide primers and chain termination.

Pacific Biosciences of California, Inc. (Nasdaq:PACB), a leading provider of high-quality, long-read sequencing platforms, today announced that the Wellcome Sanger Institute has committed to purchase seven new Sequel IIe Systems and upgrade its five existing Sequel II Systems to increase its long-read sequencing capabilities for projects including the Darwin Tree of Life (DToL; all eukaryotes in Britain and Ireland) and Aquatic Symbiosis G

The “chain termination method,” often known as Sanger sequencing, is a method for determining the nucleotide sequence of deoxyribonucleic acid (DNA).

Capillary electrophoresis, which enables Sanger sequencing and fragment analysis, is an important tool for improving clinical research and advancing scientific discovery.